782 related articles for article (PubMed ID: 9369136)
1. Planning, delivery, and quality assurance of intensity-modulated radiotherapy using dynamic multileaf collimator: a strategy for large-scale implementation for the treatment of carcinoma of the prostate.
Burman C; Chui CS; Kutcher G; Leibel S; Zelefsky M; LoSasso T; Spirou S; Wu Q; Yang J; Stein J; Mohan R; Fuks Z; Ling CC
Int J Radiat Oncol Biol Phys; 1997 Nov; 39(4):863-73. PubMed ID: 9369136
[TBL] [Abstract][Full Text] [Related]
2. A quantitative study of IMRT delivery effects in commercial planning systems for the case of oesophagus and prostate tumours.
Seco J; Clark CH; Evans PM; Webb S
Br J Radiol; 2006 May; 79(941):401-8. PubMed ID: 16632620
[TBL] [Abstract][Full Text] [Related]
3. Dosimetric verification of inverse planned step and shoot multileaf collimator fields from a commercial treatment planning system.
MacKenzie MA; Lachaine M; Murray B; Fallone BG; Robinson D; Field GC
J Appl Clin Med Phys; 2002; 3(2):97-109. PubMed ID: 11958650
[TBL] [Abstract][Full Text] [Related]
4. Conformal radiation treatment of prostate cancer using inversely-planned intensity-modulated photon beams produced with dynamic multileaf collimation.
Ling CC; Burman C; Chui CS; Kutcher GJ; Leibel SA; LoSasso T; Mohan R; Bortfeld T; Reinstein L; Spirou S; Wang XH; Wu Q; Zelefsky M; Fuks Z
Int J Radiat Oncol Biol Phys; 1996 Jul; 35(4):721-30. PubMed ID: 8690638
[TBL] [Abstract][Full Text] [Related]
5. Acceptance tests and quality control (QC) procedures for the clinical implementation of intensity modulated radiotherapy (IMRT) using inverse planning and the sliding window technique: experience from five radiotherapy departments.
Van Esch A; Bohsung J; Sorvari P; Tenhunen M; Paiusco M; Iori M; Engström P; Nyström H; Huyskens DP
Radiother Oncol; 2002 Oct; 65(1):53-70. PubMed ID: 12413675
[TBL] [Abstract][Full Text] [Related]
6. DMLC tracking and gating can improve dose coverage for prostate VMAT.
Colvill E; Poulsen PR; Booth JT; O'Brien RT; Ng JA; Keall PJ
Med Phys; 2014 Sep; 41(9):091705. PubMed ID: 25186380
[TBL] [Abstract][Full Text] [Related]
7. Implementation of phantom-less IMRT delivery verification using Varian DynaLog files and R/V output.
Agnew CE; King RB; Hounsell AR; McGarry CK
Phys Med Biol; 2012 Nov; 57(21):6761-77. PubMed ID: 23032423
[TBL] [Abstract][Full Text] [Related]
8. Differential dosing of prostate and seminal vesicles using dynamic multileaf collimation.
Klein EE; Low DA; Sohn JW; Purdy JA
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1447-56. PubMed ID: 11121647
[TBL] [Abstract][Full Text] [Related]
9. Quantifying the effect of intrafraction motion during breast IMRT planning and dose delivery.
George R; Keall PJ; Kini VR; Vedam SS; Siebers JV; Wu Q; Lauterbach MH; Arthur DW; Mohan R
Med Phys; 2003 Apr; 30(4):552-62. PubMed ID: 12722807
[TBL] [Abstract][Full Text] [Related]
10. IMRT of large fields: whole-abdomen irradiation.
Hong L; Alektiar K; Chui C; LoSasso T; Hunt M; Spirou S; Yang J; Amols H; Ling C; Fuks Z; Leibel S
Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):278-89. PubMed ID: 12183002
[TBL] [Abstract][Full Text] [Related]
11. Comparison of intensity-modulated radiotherapy and forward-planning dynamic arc therapy techniques for prostate cancer.
Metwaly M; Awaad AM; El-Sayed EM; Sallam ASM
J Appl Clin Med Phys; 2008 Oct; 9(4):37-56. PubMed ID: 19020481
[TBL] [Abstract][Full Text] [Related]
12. Impact of leaf motion constraints on IMAT plan quality, deliver accuracy, and efficiency.
Chen F; Rao M; Ye JS; Shepard DM; Cao D
Med Phys; 2011 Nov; 38(11):6106-18. PubMed ID: 22047375
[TBL] [Abstract][Full Text] [Related]
13. IMRT implementation and patient specific dose verification with film and ion chamber array detectors.
Sathiyan S; Ravikumar M; Varatharaj C; Supe SS; Keshava SL
Gulf J Oncolog; 2010 Jul; (8):20-7. PubMed ID: 20601335
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic IMRT for prostate cancer: dosimetric impact of multileaf collimator leaf width in the treatment of prostate cancer with IMRT.
Wang L; Movsas B; Jacob R; Fourkal E; Chen L; Price R; Feigenberg S; Konski A; Pollack A; Ma C
J Appl Clin Med Phys; 2004; 5(2):29-41. PubMed ID: 15738911
[TBL] [Abstract][Full Text] [Related]
15. Commissioning and quality assurance for intensity modulated radiotherapy with dynamic multileaf collimator: experience of the Pontificia Universidad Católica de Chile.
Venencia CD; Besa P
J Appl Clin Med Phys; 2004; 5(3):37-54. PubMed ID: 15753938
[TBL] [Abstract][Full Text] [Related]
16. Quality assurance of serial tomotherapy for head and neck patient treatments.
Low DA; Chao KS; Mutic S; Gerber RL; Perez CA; Purdy JA
Int J Radiat Oncol Biol Phys; 1998 Oct; 42(3):681-92. PubMed ID: 9806530
[TBL] [Abstract][Full Text] [Related]
17. Phantomless patient-specific TomoTherapy QA via delivery performance monitoring and a secondary Monte Carlo dose calculation.
Handsfield LL; Jones R; Wilson DD; Siebers JV; Read PW; Chen Q
Med Phys; 2014 Oct; 41(10):101703. PubMed ID: 25281942
[TBL] [Abstract][Full Text] [Related]
18. Clinical implementation of intensity-modulated arc therapy.
Yu CX; Li XA; Ma L; Chen D; Naqvi S; Shepard D; Sarfaraz M; Holmes TW; Suntharalingam M; Mansfield CM
Int J Radiat Oncol Biol Phys; 2002 Jun; 53(2):453-63. PubMed ID: 12023150
[TBL] [Abstract][Full Text] [Related]
19. Impact of the MLC leaf-tip model in a commercial TPS: Dose calculation limitations and IROC-H phantom failures.
Koger B; Price R; Wang D; Toomeh D; Geneser S; Ford E
J Appl Clin Med Phys; 2020 Feb; 21(2):82-88. PubMed ID: 31961036
[TBL] [Abstract][Full Text] [Related]
20. IMAT-SIM: a new method for the clinical dosimetry of intensity-modulated arc therapy (IMAT).
Iori M; Cagni E; Nahum AE; Borasi G
Med Phys; 2007 Jul; 34(7):2759-73. PubMed ID: 17821983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
